Form 4 Tracker
Acumen Pharmaceuticals, Inc.
ABOS

9 insider filings · Latest: Jun 3, 2026

Common Stock Transactions

No transactions found.

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 3, 2026Jun 5 5:12 PMRA CAPITAL MANAGEMENT, L.P.Director, 10% Owner
Grant/Award
53,250$2.2953,250(I)

View →

Jun 3, 2026Jun 5 4:32 PMNathan B FountainDirector
Grant/Award
53,250$2.2953,250(D)

View →

Jun 3, 2026Jun 5 4:31 PMKimberlee C DrapkinDirector
Grant/Award
53,250$2.2953,250(D)

View →

Jun 3, 2026Jun 5 4:30 PMJohn A Stalfort IIIDirector
Grant/Award
53,250$2.2953,250(D)

View →

Jun 3, 2026Jun 5 4:30 PMDerrell PorterDirector
Grant/Award
53,250$2.2953,250(D)

View →

Jun 3, 2026Jun 5 4:29 PMJeffrey L. IvesDirector
Grant/Award
53,250$2.2953,250(D)

View →

Jun 3, 2026Jun 5 4:28 PMGeorge GolumbeskiDirector
Grant/Award
53,250$2.2953,250(D)

View →

Jun 3, 2026Jun 5 4:27 PMLaura StoppelDirector
Grant/Award
53,250$2.2953,250(D)

View →